Document Detail


Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.
MedLine Citation:
PMID:  16495766     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate extended-release doxazosin gastrointestinal therapeutic system (GITS) as add-on therapy in patients with treated, but uncontrolled hypertension. METHODS: A 16-week, open, noncomparative, multicenter, prospective study of patients with hypertension (> or = 140/> or = 90 mm Hg). Doxazosin GITS 4 mg/d was added to entry medication and increased to 8 mg/d at Week 4 in cases of inadequate blood pressure (BP) control. RESULTS: A total of 3631 patients (40% women) with mean age of 62.4 +/- 0.2 years were included. Proportion of patients reaching goal (< 140/< 90 mm Hg) after 4 weeks of add-on therapy with doxazosin GITS was 39% and increased to 61% at Week 16. Systolic and diastolic BP (mean +/- SEM) decreased, respectively, from 161.6 +/- 0.2 and 95.1 +/- 0.1 mm Hg at baseline to 142.2 +/- 0.2 and 84.1 +/- 0.1 mm Hg at Week 4 (P < 0.0001) and 136.8 +/- 0.2 and 80.6 +/- 0.2 mm Hg at Week 16 (P < 0.0001). Adverse events occurred in 108 patients (3.0%), with 57 (1.6%) related to the study treatment. In 17 patients (0.5%), serious adverse events were described, but only one was related to the study drug. CONCLUSIONS: Doxazosin GITS as add-on therapy achieved target blood pressure and was well tolerated in patients with hypertension uncontrolled by previous regimens. Doxazosin GITS efficacy and tolerability was achieved in combination with all classes of antihypertensives tested.
Authors:
Fernando de Alvaro; Miguel Angel Hernández-Presa;
Related Documents :
1729066 - Effects of long-term treatment with prazosin on left ventricular diastolic function in ...
11641316 - Pulse pressure changes with six classes of antihypertensive agents in a randomized, con...
8613276 - Community-based education classes for hypertension control. a 1.5-year randomized contr...
8517426 - Comparison of bisoprolol with atenolol for systemic hypertension in four population gro...
23889536 - Analysis of pressure head-flow loops of pulsatile rotodynamic blood pumps.
3992216 - Blood pressure and other cardiovascular risk factors of long-term exposure to lead.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  47     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-02-23     Completed Date:  2006-07-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  271-6     Citation Subset:  IM    
Affiliation:
Hypertension Unit, Nephrology Department, Hospital Universitario La Paz, Madrid, Spain. fdealvaro@infonegocio.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / administration & dosage,  adverse effects,  therapeutic use*
Blood Pressure / drug effects
Delayed-Action Preparations
Digestive System / metabolism*
Doxazosin / administration & dosage,  adverse effects,  therapeutic use*
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Hypertension / drug therapy*
Male
Middle Aged
Receptors, Adrenergic, alpha-1 / antagonists & inhibitors*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Delayed-Action Preparations; 0/Receptors, Adrenergic, alpha-1; 74191-85-8/Doxazosin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy pho...
Next Document:  Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP chann...